We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 11 OCTOBER 2017
Alexion Ordered To Significantly Reduce Cost Of Soliris

Torys
Contributor

Torys
Torys LLP is an international business law firm that works with clients who expect the best advice...
View firm profileOn September 27, a two-member panel hearing of the PMPRB issued a rare excessive-pricing decision relating to the drug Soliris (eculizumab), manufactured by Alexion Pharmaceuticals Inc. (Alexion).
CanadaIntellectual Property





